(a) Identification.
         Quality control material for cystic fibrosis nucleic acid assays. A quality control material for cystic fibrosis nucleic acid assays is a device intended to help monitor reliability of a test system by detecting analytical deviations such as those that may arise from reagent or instrument variation in genetic testing. This type of device includes recombinant, synthetic, and cell line-based DNA controls.
     
    
        
        (b) Classification.
         Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document:  Quality Control Material for Cystic Fibrosis Nucleic Acid Assays.” See  § 866.1(e) for the availability of this guidance document.
     
    
        
            Code of Federal Regulations
        
        [72 FR 1176, Jan. 10, 2007]